(Q37689790)

22 August 2017

1 reference

title

The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm (English)

1 reference

22 August 2017

main subject

arterial hypertension

0 references

author name string

Roland E Schmieder

series ordinal

1

1 reference

22 August 2017

publication date

1 January 2010

1 reference

Clinical and Experimental Hypertension

22 August 2017

published in

1 reference

22 August 2017

volume

32

1 reference

22 August 2017

issue

1

1 reference

22 August 2017

page(s)

35-42

1 reference

Global burden of blood-pressure-related disease, 2001.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Fixed-dose combinations improve medication compliance: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Controversies in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Renin-angiotensin system and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Dihydropyridine calcium channel antagonists in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Antihypertensive effects of two fixed-dose combinations of losartan and hydrochlorothiazide versus hydrochlorothiazide monotherapy in subjects with ambulatory systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Pharmacologic profile of amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Use of an olmesartan medoxomil-based treatment algorithm for hypertension control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

Carotid Intima-Media Thickness and Antihypertensive Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641960902960532

10.3109/10641960902960532

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference